Rampart Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,370
Closed -$181K 377
2020
Q3
$181K Sell
1,370
-2,578
-65% -$337K 0.11% 183
2020
Q2
$458K Buy
3,948
+2,163
+121% +$249K 0.08% 269
2020
Q1
$175K Sell
1,785
-1,909
-52% -$250K 0.08% 213
2019
Q4
$537K Sell
3,694
-19
-0.5% -$2.62K 0.07% 299
2019
Q3
$495K Sell
3,713
-227
-6% -$29.3K 0.06% 306
2019
Q2
$450K Sell
3,940
-255
-6% -$29.9K 0.05% 333
2019
Q1
$520K Buy
4,195
+1,939
+86% +$220K 0.06% 309
2018
Q4
$227K Sell
2,256
-4,820
-68% -$542K 0.06% 245
2018
Q3
$297K Sell
7,076
-1,955
-22% -$232K 0.13% 173
2018
Q2
$977K Buy
9,031
+544
+6% +$59.2K 0.1% 266
2018
Q1
$898K Buy
8,487
+5,897
+228% +$685K 0.09% 259
2017
Q4
$303K Sell
2,590
-228
-8% -$25.8K 0.12% 199
2017
Q3
$320K Buy
2,818
+151
+6% +$17.4K 0.11% 211
2017
Q2
$332K Buy
2,667
+2,099
+370% +$249K 0.12% 194
2017
Q1
$67K Buy
+568
New +$64.4K 0.02% 219

Other funds holding ZBH

Rampart Investment Management's ZBH Position: Q4 2020 in Review

Rampart Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 1,370 shares — an estimated $181K sold.

Rampart Investment Management first reported a position in ZBH in Q1 2017 and held it in 15 quarters. The position peaked at $977K in Q2 2018. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Rampart Investment Management reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 1,370 Zimmer Biomet shares in Q4 2020, an estimated $181K.
  • Rampart Investment Management first reported a position in Zimmer Biomet in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Zimmer Biomet position peaked at $977K in Q2 2018.
  • 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.